Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Fairmount Healthcare Fund Ii Gp Llc
Over the trailing 90 days, Fairmount Healthcare Fund Ii Gp Llc (Director at Viridian Therapeutics, Inc.\DE) bought $20.0M of stock in VRDN, per 1 SEC Form 4 transaction.
- Role
- Director
- Companies
- VRDN
- Window
- Trailing 90 days · 1 transactions · CIK 1830382
- Net activity
- +$20.0M ($20.0M bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | 1 | $20.0M | — | $20.0M |
Transactions (1)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-11 | VRDN | Buy | 1.2M | $20.0M | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Fairmount's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.